Webinar: Harnessing the Power of Multifunctional Antibodies for Disease Treatment
Last updated: January 2025
Join us for an insightful webinar brought to you by the Science/AAAS Custom Publishing Office, sponsored by Sartorius. Discover the cutting-edge advancements in immunotherapy with a focus on multifunctional antibodies, a promising approach for treating autoimmune disorders and cancers.
Overview
T cells and natural killer (NK) cells are crucial components of the immune system, capable of being directed to tumor sites through pro-inflammatory chemokines. Recent advancements in T cell- and NK cell-mediated immunotherapies have opened new avenues for disease treatment. This webinar will delve into the innovative use of bi- and multi-specific antibodies, which serve as effective bridges to recruit and activate immune cells at tumor sites.
Important Highlights:
- Perspectives on generating single-domain antibody-based bi- and multi-specific antibodies
- Insights into how bispecific antibodies can mimic cytokine functions
- Knowledge on creating NK cell engagers based on the NKp30 receptor
- Answers to the questions asked during the live broadcast
Key Takeaways
- Innovative Immunotherapy: Discover how T cells and natural killer (NK) cells are being harnessed through bi- and multi-specific antibodies to target and destroy tumor cells.
- Bi- and Multi-Specific Antibodies: Learn how these structures enhance immunomodulation by effectively bridging and activating immune cells.
- Cytokine Mimetics: Explore the creation of cytokine mimetics that activate the IL-18 receptor, crucial for cancer treatment, while resisting natural decoy receptors.
- NK Cell Engagers: Understand the development of NK cell engagers that bind to tumor-associated antigens and activate NK cells, facilitating tumor cell destruction.
Webinar Speaker
Stefan Zielonka, Ph.D.
Senior Director at Merck Healthcare KGaA (EMD Serono), Germany, Dr. Zielonka leads Global Antibody Discovery and Protein Engineering. With a Ph.D. in chemistry and a habilitation in biochemistry, he is also a professor of biomolecular immunotherapy at the Technical University of Darmstadt, Germany.
Don't miss this opportunity to explore the future of disease treatment with multifunctional antibodies. Register now to gain insights from a leading expert in the field!